Co-Diagnostics Inc’s CoPrimer technology powers coronavirus saliva test now available through Walgreens FInd Care digital health platform


Co-Diagnostics Inc's CoPrimer technology powers coronavirus saliva test now available through Walgreens FInd Care digital health platform

The COVID-19 RT-PCR test is being sold by Clinical Reference Laboratory under its CRL HealthConfirm brand name for $119 per kit

Co-Diagnostics Inc (NASDAQ:CODX) patented CoPrimer technology is part of a coronavirus (COVID-19) saliva test that is now available through Walgreens Find Care, a digital health platform on the retailer’s website and mobile app. 

The company’s COVID-19 RT-PCR test is being sold by Clinical Reference Laboratory under its CRL HealthConfirm brand name for $119 per kit, according to a CRL statement released Wednesday. Using Walgreens Find Care, users can access CRL’s website to see if they meet the guidelines to order the test. 

Once the kit arrives, individuals register their test online, deposit a saliva sample in the collection vial and return it using the prepaid FedEx Priority Overnight shipping package. Results are typically available within 24-48 hours, CRL said, and are delivered via text or voice message. In the event of a positive test, an independent telemedicine provider will reach out. 

READ: Co-Diagnostics appoints long-time executive Brian Brown as its new chief financial officer

In addition to Co-Diagnostics technology, the saliva test also incorporates technology from DNA Genotek. First, a saliva sample is collected in a DNA Genotek OMNIgene saliva collection device, then it’s tested for the coronavirus using Co-Diagnostics patented CoPrimer technology. 

“Increasing access to COVID-19 testing is a priority for Walgreens and CRL’s at-home test provides a convenient way to offer testing and care when and how patients need it,” Walgreens Boots Alliance Healthcare Services SVP Giovanni Monti said in a statement. “This adds to the growing list of healthcare and COVID offerings available through Walgreens Find Care to help our communities access care when and how they need it.”

The CRL test received FDA Emergency Use Authorization in July 2020. The company has distributed and processed more than 500,000 tests across the education, media, finance, government, sports and other sectors. 

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com

Follow him on Twitter @andrew_kessel


Source link